About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Progress in Pharmaceutical and Biomedical Analysis
›
top-articles
Progress in Pharmaceutical and Biomedical Analysis
0.1
(top 100%)
impact factor
113
(top 100%)
papers
226
(top 50%)
citations
7
(top 50%)
h
-index
0.1
(top 100%)
extended IF
139
all documents
248
doc citations
11
(top 50%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Chapter 1 Principles of capillary electrophoresis
Progress in Pharmaceutical and Biomedical Analysis
1996
14
2
Chapter 2 Statistical parameters and analytical figures of merit
Progress in Pharmaceutical and Biomedical Analysis
1996
12
3
Chapter 6 Metabolite identification by lc-ms: applications in drug discovery and development
Progress in Pharmaceutical and Biomedical Analysis
2005
10
4
Chapter 5 Capillary electrophoresis/Mass spectrometry
Progress in Pharmaceutical and Biomedical Analysis
1996
9
5
Solid Phase Extraction for Sample Preparation
Progress in Pharmaceutical and Biomedical Analysis
1994
8
6
Chapter 9 Quantification and structural elucidation of low quantities of radiolabeled metabolites using microplate scintillation counting (msc) techniques in conjunction with lc-ms
Progress in Pharmaceutical and Biomedical Analysis
2005
8
7
2.7.5. HPLC/NMR and related hyphenated NMR methods
Progress in Pharmaceutical and Biomedical Analysis
2000
7
8
2.7 High performance liquid chromatography (HPLC) and related techniques
Progress in Pharmaceutical and Biomedical Analysis
2000
7
9
Chapter 3 Electrokinetic chromatography
Progress in Pharmaceutical and Biomedical Analysis
1996
6
10
2.10. Supercritical fluid chromatography (SFC)
Progress in Pharmaceutical and Biomedical Analysis
2000
6
11
2.9. Capillary electrochromatography (CEC)
Progress in Pharmaceutical and Biomedical Analysis
2000
5
12
6.4. Polarimetry, ORD and CD spectroscopy
Progress in Pharmaceutical and Biomedical Analysis
2000
5
13
Chapter 10 Oxidative metabolites of drugs and xenobiotics: lc-ms methods to identify and characterize in biological matrices
Progress in Pharmaceutical and Biomedical Analysis
2005
5
14
Chapter 11 Detection and characterization of highly polar metabolites by lc-ms: proper selection of lc column and use of stable isotope-labeled drug to study metabolism of ribavirin in rats
Progress in Pharmaceutical and Biomedical Analysis
2005
5
15
Development and Validation of Liquid Chromatographic Assays for the Regulatory Control of Pharmaceuticals
Progress in Pharmaceutical and Biomedical Analysis
1994
5
16
A Comprehensive Method Validation Strategy for Bioanalytical Applications in the Pharmaceutical Industry
Progress in Pharmaceutical and Biomedical Analysis
1994
5
17
2.7 High performance liquid chromatography (HPLC) and related techniques
Progress in Pharmaceutical and Biomedical Analysis
2000
4
18
2.4. NMR spectroscopy
Progress in Pharmaceutical and Biomedical Analysis
2000
4
19
Chapter 9 Liquid-liquid extraction: Strategies for method development and optimization
Progress in Pharmaceutical and Biomedical Analysis
2003
4
20
Chapter 10 Separation of nucleic acids and oligonucleotides and sequencing of DNA Fragments by capillary electrophoresis
Progress in Pharmaceutical and Biomedical Analysis
1996
3
21
1.2 The nature and origin of the impurities in drug substances
Progress in Pharmaceutical and Biomedical Analysis
2000
3
22
1.1. Introductory remarks
Progress in Pharmaceutical and Biomedical Analysis
2000
3
23
2.7 High performance liquid chromatography (HPLC) and related techniques
Progress in Pharmaceutical and Biomedical Analysis
2000
3
24
1.3. Toxicological aspects
Progress in Pharmaceutical and Biomedical Analysis
2000
3
25
2.8. Determination of drug related impurities by capillary electrophoresis
Progress in Pharmaceutical and Biomedical Analysis
2000
3
26
2.1. Strategies in impurity profiling
Progress in Pharmaceutical and Biomedical Analysis
2000
3
27
Chapter 3 Commonly encountered analytical problems and their solutions in liquid chromatography/ tandem mass spectrometry (LC/MS/MS) methods used in drug development
Progress in Pharmaceutical and Biomedical Analysis
2005
3
28
On-Line Microdialysis Sampling
Progress in Pharmaceutical and Biomedical Analysis
1994
3
29
Chapter 7 Sample preparation for capillary electrophoresis
Progress in Pharmaceutical and Biomedical Analysis
1996
2
30
Chapter 9 Capillary electrophoresis of proteins and peptides
Progress in Pharmaceutical and Biomedical Analysis
1996
2
31
2.3. Mass spectrometry in impurity profiling
Progress in Pharmaceutical and Biomedical Analysis
2000
2
32
2.5. Planar chromatography
Progress in Pharmaceutical and Biomedical Analysis
2000
2
33
1.5. Regulatory aspects: ICH and pharmacopoeial perspectives
Progress in Pharmaceutical and Biomedical Analysis
2000
2
34
1.4. The role of impurity profiling in drug research, development and production
Progress in Pharmaceutical and Biomedical Analysis
2000
2
35
2.9. Capillary electrochromatography (CEC)
Progress in Pharmaceutical and Biomedical Analysis
2000
2
36
9.4. Steroids
Progress in Pharmaceutical and Biomedical Analysis
2000
2
37
Chapter 6 Protein precipitation: High throughput techniques and strategies for method development
Progress in Pharmaceutical and Biomedical Analysis
2003
2
38
Chapter 2 Fundamental strategies for bioanalytical sample preparation
Progress in Pharmaceutical and Biomedical Analysis
2003
2
39
Chapter 5 In vitro dmpk screening in drug discovery, role of lc-ms/ms
Progress in Pharmaceutical and Biomedical Analysis
2005
2
40
Chapter 2 Strategies for increasing throughput for pk samples in a drug discovery environment
Progress in Pharmaceutical and Biomedical Analysis
2005
2
41
Chapter 12 Cytochrome p450 (cyp) and udp-glucuronosyltransferase (ugt) enzymes: role in drug metabolism, polymorphism, and identification of their involvement in drug metabolism
Progress in Pharmaceutical and Biomedical Analysis
2005
2
42
Pharmaceutical and Biomedical Applications of Capillary Electrophoresis
Progress in Pharmaceutical and Biomedical Analysis
1994
2
43
Novel Approaches to the Liquid Chromatographic Analysis of Primary Amines, Amino Acids and Peptides
Progress in Pharmaceutical and Biomedical Analysis
1994
2
44
Multi-column Approaches to Chiral Bioanalysis by Liquid Chromatography
Progress in Pharmaceutical and Biomedical Analysis
1994
2
45
Chapter 9 Biotechnology products
Progress in Pharmaceutical and Biomedical Analysis
1996
1
46
Chapter 11 Analytical methods for cleaning procedures
Progress in Pharmaceutical and Biomedical Analysis
1996
1
47
Chapter 2 Column technologies for capillary electrophoresis
Progress in Pharmaceutical and Biomedical Analysis
1996
1
48
Chapter 4 Optical detection strategies in capillary electrophoresis
Progress in Pharmaceutical and Biomedical Analysis
1996
1
49
Chapter 12 Capillary electrophoresis-based methods for in vivo analysis: Single cell analysis and microdialysis sampling
Progress in Pharmaceutical and Biomedical Analysis
1996
1
50
Chapter 4 Issues related to the United States v. Barr Laboratories, Inc.
Progress in Pharmaceutical and Biomedical Analysis
1996
1
site/software ©
exaly
; All materials licenced under
CC by-SA
.